Clonidine prevents insulin resistance and hypertension in obese dogs

被引:64
作者
Rocchini, AP
Mao, HZ
Babu, K
Marker, P
Rocchini, AJ
机构
[1] Univ Michigan, Div Pediat Cardiol, Ann Arbor, MI 48109 USA
[2] Univ Minnesota, Dept Pediat, Div Pediat Cardiol, Minneapolis, MN 55455 USA
[3] Childrens Mem Hosp, Div Pediat Cardiol, Chicago, IL 60614 USA
[4] Northwestern Univ, Chicago, IL 60611 USA
关键词
hypertension; arterial; obesity; insulin resistance; clonidine; sympathetic nervous system; cardiac output;
D O I
10.1161/01.HYP.33.1.548
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The role that the central sympathetic nervous system plays in the development of obesity hypertension and insulin was evaluated by feeding dogs a high fat diet with or without clonidine treatment. Thirteen adult mongrel dogs were chronically instrumented and randomly assigned to receive either a high fat diet and no clonidine (n=6) or a high fat diet plus clonidine (n=7), 0.3 mg BID. Blood pressure, heart rate, plasma insulin, and electrolytes were measured daily. Insulin resistance was assessed with a multiple-dose euglycemic clamp (1, 2, and 30 mU.kg(-1).min(-1)) before and after 1, 3, and 6 weeks of the high fat diet. Clonidine prevented the hypertension, tachycardia, and insulin resistance associated with feeding dogs the high fat diet but did not affect weight gain. The present study suggests that the central sympathetic nervous system plays a critical role in the development of both insulin resistance and hypertension associated with feeding dogs a high fat diet.
引用
收藏
页码:548 / 553
页数:6
相关论文
共 29 条
[1]   ORAL GLUCOSE-TOLERANCE AND INSULIN-RESPONSE AFTER ONE WEEK CLONIDINE TREATMENT IN HYPERTENSIVE PATIENTS [J].
BARBIERI, C ;
CALDARA, R ;
TESTORI, G ;
PIEPOLI, V ;
TREZZI, R ;
ROMUSSI, M ;
FERRARI, C .
ACTA DIABETOLOGICA LATINA, 1981, 18 (01) :59-63
[2]   MECHANISM OF INSULIN RESISTANCE IN INSULIN-DEPENDENT DIABETES-MELLITUS - A MAJOR ROLE FOR REDUCED SKELETAL-MUSCLE BLOOD-FLOW [J].
BARON, AD ;
LAAKSO, M ;
BRECHTEL, G ;
EDELMAN, SV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (03) :637-643
[3]  
DELEAN A, 1978, AM J PHYSIOL, V235, P97
[4]  
DIEBERT DC, 1980, J CLIN INVEST, V65, P717
[5]   The I-1-imidazoline receptor: From binding site to therapeutic target in cardiovascular disease [J].
Ernsberger, P ;
Friedman, JE ;
Koletsky, RJ .
JOURNAL OF HYPERTENSION, 1997, 15 :S9-S23
[6]  
FERRANNINI E, 1990, J CARDIOVASC PHAR S5, V15, P18
[7]   ESTIMATION OF ENDOGENOUS GLUCOSE-PRODUCTION DURING HYPERINSULINEMIC-EUGLYCEMIC GLUCOSE CLAMPS - COMPARISON OF UNLABELED AND LABELED EXOGENOUS GLUCOSE INFUSATES [J].
FINEGOOD, DT ;
BERGMAN, RN ;
VRANIC, M .
DIABETES, 1987, 36 (08) :914-924
[8]   Hemodynamic and metabolic effects of transdermal clonidine in patients with hypertension and non-insulin-dependent diabetes mellitus [J].
Giugliano, D ;
Acampora, R ;
Marfella, R ;
La Marca, C ;
Marfella, M ;
Nappo, F ;
D'Onofrio, F .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (02) :184-189
[9]  
HALL JE, 1992, CIRCULATION, V86, P541
[10]   CHRONIC HYPERINSULINEMIA AND BLOOD-PRESSURE - INTERACTION WITH CATECHOLAMINES [J].
HALL, JE ;
BRANDS, MW ;
KIVLIGHN, SD ;
MIZELLE, HL ;
HILDEBRANDT, DA ;
GAILLARD, CA .
HYPERTENSION, 1990, 15 (05) :519-527